The following article was featured in:
Source:
Section Page News - Crain's New York Business
03/10/2025.
CORRECTION: Canaccord Genuity was involved in the placement of only a portion, not all, of the 14 million shares Midtown-based Lucid Diagnostics recently sold. This information was updated in the...
Continue on to full article...
